2246.5000 -58.50 (-2.54%)
NSE Aug 19, 2026 15:31 PM
Volume: 833.6K
 

2246.50
-2.54%
Deven Choksey
We have revised our FY26E/FY27E EPS estimates by -1.1 %/+13.2%, respectively, as we factor in improvement in EBITDA margins on account of improving mix and launch of high margin products.
Glenmark Pharmaceuti.. has an average target of 2434.50 from 4 brokers.
More from Glenmark Pharmaceuticals Ltd.
Recommended